CDX-505

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCDX-505
Drug Alias NameProstatixantioxidant prodrug (Cardax Pharmaceuticals)CDX-505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionantioxidant
TargetsUpdating
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCardax Pharmaceuticals INC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A